statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dyadic International ( NASDAQ:DYAI ) Full Year 2023 Results Key Financial Results Revenue: US$2.90m (down 1.1% from FY...

Dyadic International Full Year 2023 Earnings: Misses Expectations

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
DYAI stock results show that Dyadic International missed analyst estimates for earnings per share and missed on revenue for the fourth...

DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q4 2023

Dyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcript...

Dyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcript

JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ( Dyadic , we , us , our , or the Company ) (NASDAQ: DYAI), a biotechnology company focused on the efficient...

Dyadic Announces Change in Board and Management Leadership Roles

Recap: Dyadic International Q4 Earnings

Dyadic International (DYAI) has provided an update. On March 26, 2024, the board of directors of a prominent company announced significant leadersh...

Dyadic International Announces Key Leadership Changes

Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...

Dyadic Reports 2023 Full Year Results and Recent Company Progress

Enzon Pharmaceuticals (OTCMKTS:ENZN  Get Free Report) and Dyadic International (NASDAQ:DYAI  Get Free Report) are both medical companies, but which is the better stock? We will contrast...

Head-To-Head Contrast: Dyadic International (NASDAQ:DYAI) & Enzon Pharmaceuticals (OTCMKTS:ENZN)

JUPITER, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ( Dyadic , or the Company ) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...

Dyadic to Attend Industry Events in April

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.

Watchers	1,815
52-Wk Low	$1.19
52-Wk High	$2.40

Volume	191,275.00
52-Wk High	$2.40
52-Wk Low	$1.19

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.07	--	--	N/A
Q1'24	--	-$0.07	--	N/A
Q4'23	-$0.07	-$0.08	-23.08%	MISSED
Q3'23	-$0.06	-$0.06	--	EXPECTED
Q2'23	-$0.05	-$0.07	-40.00%	MISSED

DYAI Dyadic International Inc., DE

About

Feed

News

Sentiment

Earnings

Fundamentals